Corindus Vascular Robotics (CVRS) Misses Q3 EPS by 1c

Corindus Vascular Robotics (NYSE: CVRS) reported Q3 EPS of ($0.07), $0.01 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $700 thousand versus the consensus estimate of $1.31 million.

For earnings history and earnings-related data on Corindus Vascular Robotics (CVRS) click here.

You May Also Be Interested In

• Tesla touts acceleration of new models, but Q1 results fall short of estimates
• Bank of N.T. Butterfield & Son (NTB) Tops Q1 EPS by 20c
• Premier Financial (PFC) Tops Q1 EPS by 3c